Interestingly, our data demonstrates that increased β-Catenin levels are able to drive Pten deficient prostate epithelia, a frequent genetic lesion in human prostate cancer, to invasive carcinoma suggesting that these pathways could interact during human prostate tumorigenesis. This evidence concerns the gene PTEN and invasive carcinoma.